Related Experiment Videos
Treatment of calcific aortic stenosis by balloon valvuloplasty
Insights
Balloon valvuloplasty effectively reduces left ventricular outflow tract obstruction in patients with calcific aortic stenosis. This minimally invasive procedure significantly improves aortic valve function with minimal complications.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Calcific aortic stenosis causes left ventricular outflow tract obstruction.
- Balloon valvuloplasty is a reported technique to address this condition.
Purpose of the Study:
- To summarize experiences with balloon valvuloplasty for calcific aortic stenosis.
- To evaluate the efficacy and safety of balloon valvuloplasty in this patient group.
Main Methods:
- The study included 9 patients (mean age 78 years) with calcific aortic stenosis.
- Balloon valvuloplasty was performed to reduce obstruction.
Main Results:
- Peak aortic valve gradient decreased from 68 to 35 mm Hg (p=0.003).
- Mean aortic valve gradient decreased from 57 to 30 mm Hg (p=0.006).
- Aortic valve area increased from 0.42 to 0.81 cm2 (p=0.005).
- No significant aortic regurgitation was observed.
- One patient experienced a brain stem infarct; another had femoral arterial blood loss.
Conclusions:
- Balloon valvuloplasty is effective in treating calcific aortic stenosis.
- The procedure is associated with potential hazards, including stroke and bleeding.
Abstract:
Recent reports have established the feasibility of using balloon valvuloplasty to reduce left ventricular outflow tract obstruction due to a calcified aortic valve. The present study summarizes experiences with this technique in 9 patients (7 women, 2 men, mean age 78 years) in whom balloon valvuloplasty was used to treat calcific aortic stenosis. Peak aortic valve gradient (mm Hg) decreased from 68 +/- 8 (mean +/- standard error of the mean) before valvuloplasty to 35 +/- 5 after valvuloplasty (p = 0.003). Mean aortic valve gradient decreased from 57 +/- 7 before valvuloplasty to 30 +/- 5 after valvuloplasty (p = 0.006). Calculated aortic valve area increased from 0.42 +/- 0.04 to 0.81 +/- 0.06 cm2 (p = 0.005). Balloon valvuloplasty failed to diminish aortic valve obstruction in only 1 patient who, at subsequent surgery, had a congenitally bicuspid aortic valve. Significant aortic regurgitation was not observed in any of the 9 patients after valvuloplasty. One patient did have a highly focal, presumably embolic, brain stem infarct during the procedure. Femoral arterial blood loss, related to wire-guided exchange of balloon catheters too large for a 12Fr introducer sheath, was minimized by direct arterial exposure in 8 of the 9 patients. Thus, these findings confirm the efficacy of balloon valvuloplasty for the treatment of calcific aortic stenosis. The procedure, however, is not without hazard.